Tradestie Institutional Equity Comparison Engine

QNRX vs VS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

QNRX Overall Edge

QNRX Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, QNRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VS at N/M Forward P/E and -136.2% operating margin (-24.7% YoY). In options structure, QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner QNRX
QNRX N/M vs VS N/M Fwd P/E
Growth & Margin Winner QNRX
Op Margin 0.0% vs -136.2% ยท YoY +0.0% vs -24.7%
Momentum & Technical Winner QNRX
1Y -82.0% vs -59.5% ยท 52W Pos 0% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
QNRX NASDAQ
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Pharmaceutical Preparations
$3.28
-2.35% 1D
Market Cap $16.1M
1M Return -18.2%
1Y Return -81.96%
Forward P/E N/M
Unified AI Score
46.1 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 64.0
VS NASDAQ
Versus Systems Inc. Common Stock
Services-Computer Processing & Data Preparation
$0.57
-17.44% 1D
Market Cap $4.3M
1M Return -40.83%
1Y Return -59.54%
Forward P/E N/M
Unified AI Score
40.6 / 100 SELL
Tech 25.0 Fund 47.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: QNRX -81.96% VS -59.54% Spread: +22.42 pp (VS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
QNRX TTM Op. Margin: 0.0% VS TTM Op. Margin: -136.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QNRX vs VS. Trailing 12-month operating profitability (QNRX 0.0% vs VS -136.2%) and valuation multiples (QNRX N/M vs VS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: QNRX (7) vs VS (1)
Institutional Metric QNRX VS Criterion Row Winner
Market Capitalization Scale $16.1M $4.3M Larger Scale QNRX
Trailing P/E Ratio Valuation 7.6x N/M Lower Multiple QNRX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -24.7% Higher Growth QNRX
Operating Margin (TTM) Profitability 0.0% -136.2% Higher Margin QNRX
Net Profit Margin Profitability 0.0% -112.8% Higher Margin QNRX
Return on Equity (ROE) Capital Efficiency -142.6% -69.2% Higher ROE VS
52-Week Range Position Momentum 0% ($3โ€“$24) 0% ($1โ€“$2) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 74% Vol 1.45ฮฒ ยท 78% Vol Lower Realized Risk QNRX
Unified Institutional Score Composite Signal 46.1 / 100 (HOLD) 40.6 / 100 (SELL) Higher Composite QNRX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full QNRX vs VS Buy Guide
QNRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live QNRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither QNRX nor VS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.